{"id":9345,"date":"2020-04-29T10:20:33","date_gmt":"2020-04-29T08:20:33","guid":{"rendered":"https:\/\/www.resist-cluster.de\/?page_id=9345"},"modified":"2021-08-31T14:01:56","modified_gmt":"2021-08-31T12:01:56","slug":"prof-dr-till-strowig","status":"publish","type":"page","link":"https:\/\/www.resist-cluster.de\/en\/about-us\/research-team-2\/prof-dr-till-strowig\/","title":{"rendered":"Prof. Dr. Till Strowig"},"content":{"rendered":"

<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/a><\/span><\/div>

Prof. Dr. Till Strowig participates in\u00a0RESIST research projects B1 and B2.<\/p>\n<\/div>

<\/div><\/div><\/div>

\n\n\n
<\/i><\/td>\nMy Research Interest in RESIST<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/h1><\/div>
\n
\n
\n

Our research focus in RESIST is the identification and validation of the role of the gastrointestinal microbiome in infections and inflammatory conditions affecting susceptible and immunocompromised individuals. Therefore, we are employing sequencing-based, microbiological and immunological approaches applying them to gnotobiotic animal models and patient cohorts in collaboration with other RESIST scientists. The long-term aim is to identify pathophysiological conditions, which could be improved by targeting the microbiome therapeutically.\u00a0<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>

<\/div>
<\/div>
<\/div>
<\/i><\/span>Contact<\/span><\/a><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/path><\/svg><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div>

Prof. Strowig about his scientific work<\/h1><\/div>
<\/span><\/div>
<\/div><\/div><\/div><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>
<\/path><\/svg><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>

Prof. Dr. Till Strowig – Curriculum Vitae<\/h1><\/div>
<\/div><\/div><\/div>

Current Position<\/h3><\/div>